The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| NAUTILUS BIOTECHNOLOGY INC | COM | 63909J108 | 23,300 | 6,020,770 | SH | SOLE | 6,020,770 | 0 | 0 | |||
| ROVER GROUP INC | COM CL A | 77936F103 | 129,938 | 26,463,916 | SH | SOLE | 26,463,916 | 0 | 0 | |||
| UIPATH INC | CL A | 90364P105 | 10,069 | 607,673 | SH | SOLE | 607,673 | 0 | 0 | |||
| BRIGHTCOVE INC | COM | 10921T101 | 178 | 44,270 | SH | SOLE | 44,270 | 0 | 0 | |||
| SNOWFLAKE INC | CL A | 833445109 | 111,155 | 631,633 | SH | SOLE | 631,633 | 0 | 0 | |||